HIV-1 p17/p55 (AA 401-460) 抗体 (Cy3)
Quick Overview for HIV-1 p17/p55 (AA 401-460) 抗体 (Cy3) (ABIN1415098)
抗原
适用
宿主
克隆类型
标记
应用范围
-
-
抗原表位
- AA 401-460
-
交叉反应
- Virus
-
交叉反应 （详细）
- HIV-1
-
纯化方法
- Purified by Protein A.
-
免疫原
- KLH conjugated synthetic peptide derived from HIV1 p55+p17/HIV1 Pr55Gag
-
亚型
- IgG
-
-
-
-
应用备注
-
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
限制
- 仅限研究用
-
-
-
状态
- Liquid
-
浓度
- 1 μg/μL
-
缓冲液
- Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.
-
储存液
- ProClin
-
注意事项
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
储存条件
- -20 °C
-
储存方法
- Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.
-
有效期
- 12 months
-
-
- HIV-1 p17/p55
-
别名
- HIV1 p55+p17
-
物质类
- Viral Protein
-
背景
-
Synonyms: HIV1 Pr55Gag, HIV1 p55 + p17 Gag antibody Gag polyprotein, HIV1 matrix protein p17, HIV1 Pr55Gag, Human immunodeficiency virus 1 p17, Human immunodeficiency virus 1 Pr55Gag, MA antibody Matrix protein p17, Pr55Gag.
Background: HIV1 performs highly complex orchestrated tasks during the assembly, budding, maturation and infection stages of the viral replication cycle. During viral assembly, the proteins form membrane associations and self-associations that ultimately result in budding of an immature virion from the infected cell. Gag precursors also function during viral assembly to selectively bind and package two plus strands of genomic RNA. HIV1 Gag p17, the HIV1 matrix protein is produced by the digestion of its precursor Gag p55 by HIV1 protease.
-
UniProt
- I7FT07
抗原
-
